Latest research

Alexza Pharmaceuticals

Stage set for Adasuve

QuickView | Pharmaceutical & Healthcare | 23/05/2013

Alexza’s US marketing deal with Teva for Adasuve (orally-inhaled loxapine) enhances the product’s US sales prospects given Teva’s expertise…

Aastrom Biosciences

Patients and cash

Update | Pharmaceutical & Healthcare | 23/05/2013

Aastrom’s Q1 results show its consolidation onto affordable clinical studies and a determination to achieve a solid cash basis. The focus is on the…

NetDimensions

Growth acceleration

Update | Technology | 22/05/2013

NetDimensions (AIM:NETD, OTCQX:NETDY) has announced a further acceleration in its growth strategy on the back of a $6.1m fund-raising in early-May. Under…

LSL Property Services

Accelerated investment on market recovery

Update | Property | 22/05/2013

The Q1 IMS confirmed that estate agency operations traded well relative to a weak market overall and strong Q112 comparatives, while surveying and valuation…

Is Yatirim Menkul Degerler

Challenging year-on-year comparatives

Update | Financials | 22/05/2013

Headline Q113 results from IS Yatirim Mekul Degerler (ISY) appear weak, with net profits down 64%, but are distorted by a number of factors. Subsidiary…